Orion Pharma pharmaceuticals

Orion Pharma is a leading Nordic pharmaceutical brand with a history stretching back over a century. Founded in 1917, the brand has grown from a local Finnish producer into a globally recognized developer and manufacturer of human and veterinary medicines. The brand is particularly well-known for its research-led approach in therapy areas such as oncology and pain management.

The manufacturing operations for Orion products are predominantly centered in Finland, where the company maintains six specialized production sites. To support its international reach and specific product lines, Orion also operates manufacturing facilities in France and Belgium. The company provides a wide range of products, from innovative protected medicines and branded legacy drugs to generic prescription medicines and self-care consumer health products.

Ownership of the brand remains tied to its roots; Orion Pharma is the pharmaceutical division of Orion Corporation. Headquartered in Espoo, Finland, the parent company is publicly listed on the Nasdaq Helsinki. This stable corporate structure allows Orion to maintain its Nordic heritage while distributing its life-enhancing products to over one hundred countries through a mix of its own sales network and strategic global partnerships.